1-866-478-3417    
Ask Dr. Gian Sample Report Log In About Us Site Content FAQ


Mycoplasma genitalium, an STD first identified in the 1980s, has now surpassed gonorrhea in prevalence among US young people, a new study reports.

Researchers at the University of Washington-Seattle tested 1,714 women and 1,218 men ages 18 to 27 who took part in Wave III of the National Longitudinal Study of Adolescent Health. Mycoplasma genitalium was diagnosed in 1.0 percent of participants, gonorrhea in 0.4 percent, and chlamydia in 4.2 percent. Mycoplasma genitalium was found to be 11 times more common in persons living with a sex partner, seven times more common among blacks, and four times more common among those who used a condom at last vaginal intercourse.

Mycoplasma genitalium can cause inflammation of the urethra in men and inflammation of the cervix and uterine lining in women, possibly leading to infertility. Most cases are asymptomatic; none of the infected study participants reported any discharge.

Lead author Dr. Lisa Manhart said there are no commercial tests for the organism, and the authors noted it is not known "whether M. genitalium-infected persons require or benefit from treatment, and if so, what antimicrobial therapy should be recommended." Manhart said, "It is probably too soon to recommend widespread screening for M. genitalium."

The full report, "Mycoplasma genitalium Among Young Adults in the United States" An Emerging Sexually Transmitted Infection," was published in the American Journal of Public Health (2007;97(6):1118-1125).

Reuters (06.07.07):: Martha Kerr

We are providing the above information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases  does not constitute  endorsement. The above summaries were prepared without conducting any additional research or investigation into the facts and statements made in the articles being summarized, and therefore readers are expressly cautioned against relying on the validity or invalidity of any statements made in these summaries. This CDC HIV/STD/TB Prevention News Update also includes information from CDC and other government agencies, such as background on MMWR articles, fact sheets and announcements.


STDWeB provides only health screening services. Tests are provided only for personal information and/or risk identification purposes. STDWeB does not diagnose or treat medical conditions.  STDWeB screenings do not take the place of a physician care.  Transactions with STDWeB are confidential and will not be shared with third parties. Tests with "positive" or "indeterminate" result may require confirmatory testing and may involve additional charges.